USMLE Step 1 gastrointestinal system questions

Histamine, released from enterochromaffin-like (ECL) cells, binds to H2 receptors on parietal cells, which are coupled to Gs proteins. This activates adenylate cyclase, increasing intracellular cAMP, which activates protein kinase A and promotes trafficking and activation of the H+/K+ ATPase (proton pump) on the apical canalicular membrane, increasing acid secretion. Gastrin and acetylcholine also stimulate acid secretion but act through Gq-coupled receptors that raise intracellular calcium rather than cAMP. This cAMP pathway is the basis for the efficacy of H2 blockers in reducing acid secretion.

• A. Gastrin acting on CCK-B receptors is also Gq-coupled, increasing intracellular calcium, not cAMP.
• B. Somatostatin acting on SST2 receptors is Gi-coupled, decreasing cAMP and inhibiting acid secretion, opposite to the described effect.
• C. Prostaglandin E2 acting on EP3 receptors is Gi-coupled, which decreases cAMP and inhibits acid secretion.
• D. Acetylcholine acting on M3 receptors is Gq-coupled, raising intracellular calcium (via IP3/DAG), not cAMP.

Proton pump inhibitors irreversibly inhibit the H+/K+ ATPase on gastric parietal cells, profoundly suppressing gastric acid secretion. Calcium carbonate requires an acidic environment for optimal absorption in the proximal small intestine; chronic hypochlorhydria from long-term PPI use reduces calcium absorption, which can lead to secondary hyperparathyroidism, decreased bone mineral density, and increased risk of osteoporotic fractures (hip, wrist, spine) with prolonged use. This is one of several recognized long-term adverse effects of PPIs, along with vitamin B12 deficiency and increased risk of Clostridioides difficile infection.

• A. PPIs are not known to directly increase renal calcium excretion as the primary mechanism of fracture risk.
• B. PPIs do not directly stimulate osteoclast-activating cytokines; bone loss is attributed to chronic calcium malabsorption rather than a cytokine-mediated mechanism.
• C. PPIs do not increase parathyroid hormone degradation; in fact, calcium malabsorption can lead to compensatory increases in parathyroid hormone secretion.
• E. PPIs do not directly inhibit osteoblast differentiation; the mechanism is related to impaired calcium absorption, not direct bone cell toxicity.

Helicobacter pylori is a gram-negative, flagellated, urease-producing organism that colonizes the gastric antrum. Urease hydrolyzes urea to ammonia, buffering acid locally and permitting bacterial survival, while the CagA virulence factor is injected into epithelial cells and disrupts cell signaling, promoting chronic inflammation. Chronic H. pylori infection causes sustained antigenic stimulation of mucosa-associated lymphoid tissue (MALT), driving clonal B-cell proliferation that can progress to MALT lymphoma; eradication of H. pylori often leads to regression of early-stage MALT lymphoma. H. pylori is also strongly linked to peptic ulcer disease and intestinal-type gastric adenocarcinoma, but the lymphoid follicle histology described here points specifically to MALT lymphoma.

• A. Gastrointestinal stromal tumors arise from interstitial cells of Cajal and are associated with KIT mutations, unrelated to H. pylori-driven lymphoid stimulation.
• B. Intestinal-type gastric adenocarcinoma is associated with H. pylori-induced chronic atrophic gastritis and intestinal metaplasia, not primarily with lymphoid follicle formation.
• D. Gastric carcinoid tumors arise from neuroendocrine (enterochromaffin-like) cells, often related to hypergastrinemia from atrophic gastritis, not from lymphoid proliferation.
• E. Leiomyosarcoma is a smooth muscle malignancy unrelated to chronic H. pylori-induced lymphoid tissue stimulation.

First-line treatment for Helicobacter pylori infection in regions with low clarithromycin resistance and no prior macrolide exposure is standard triple therapy: a proton pump inhibitor plus amoxicillin and clarithromycin for 10-14 days. The PPI raises intragastric pH, which improves antibiotic stability and efficacy while also promoting ulcer healing. Amoxicillin inhibits bacterial cell wall synthesis, and clarithromycin inhibits bacterial protein synthesis at the 50S ribosomal subunit; the combination achieves high eradication rates. Quadruple bismuth-based therapy is reserved for penicillin allergy, prior macrolide exposure, or high local clarithromycin resistance.

• A. Sucralfate is a mucosal protectant, not an antibiotic, and doxycycline/amoxicillin without a PPI is not a validated first-line regimen.
• C. Bismuth quadruple therapy requires a PPI or H2 blocker in addition to bismuth, metronidazole, and tetracycline; omitting acid suppression reduces efficacy.
• D. Ciprofloxacin and H2 blockers are not part of standard first-line H. pylori regimens; PPIs provide better acid suppression than H2 blockers in this setting.
• E. Clarithromycin and azithromycin are both macrolides, so combining them provides redundant mechanism coverage without the necessary acid suppression or cell-wall-active agent.

Duodenal ulcers, characteristically caused by H. pylori infection or NSAID use, typically present with pain that worsens 2-3 hours after meals (as the duodenum is exposed to acidic gastric contents without a food buffer) and improves with eating; they are essentially always benign. Gastric ulcers, in contrast, often worsen with eating because gastric distension stimulates further acid secretion, and they carry a small but important risk of malignant transformation, particularly intestinal-type adenocarcinoma. For this reason, all gastric ulcers require endoscopic biopsy of the ulcer margins to exclude malignancy, whereas duodenal ulcers generally do not require biopsy for cancer surveillance. Significant weight loss, as seen in Patient B, raises further concern for malignancy and mandates biopsy confirmation of healing.

• A. Blood type O is associated with increased duodenal ulcer risk in some studies, not specifically with gastric ulcer malignancy risk.
• B. Weight loss can occur with both benign and malignant ulcers and does not by itself indicate malignancy in Patient A or rule it out in Patient B; the key distinguishing feature is ulcer location, which determines biopsy necessity.
• C. Zollinger-Ellison syndrome causes multiple refractory peptic ulcers due to gastrin-secreting tumors but is not the typical cause of most gastric ulcers and is not itself defined as malignant ulcer tissue.
• E. Gastric ulcers do not heal faster than duodenal ulcers, and malignant seeding of an ulcer base is not the accepted mechanism of gastric cancer risk.

NSAIDs such as ibuprofen inhibit cyclooxygenase-1 (COX-1), which is constitutively expressed in the gastric mucosa and is responsible for synthesizing prostaglandins (particularly PGE2) that stimulate mucus and bicarbonate secretion, maintain mucosal blood flow, and promote epithelial turnover. Chronic COX-1 inhibition reduces these protective prostaglandins, weakening the mucosal barrier and increasing susceptibility to acid-induced injury, ulceration, and bleeding. This mechanism underlies the gastric toxicity seen with long-term NSAID use and is the rationale for co-prescribing a PPI or misoprostol (a PGE1 analog) in high-risk patients.

• A. NSAIDs do not increase pepsinogen production by chief cells; the primary mechanism of injury is loss of mucosal protective factors, not increased proteolytic enzyme secretion.
• B. NSAIDs do not directly increase gastrin secretion; the ulcerogenic mechanism is prostaglandin-mediated loss of mucosal protection.
• D. NSAID-induced ulcers result from impaired mucosal defense, not from direct bacterial invasion; H. pylori is a separate cause of peptic ulcer disease.
• E. NSAIDs do not act by increasing mast cell histamine release; their effect is through COX inhibition, not histamine pathways.

Whipple disease is caused by the gram-positive actinomycete Tropheryma whippelii, which infects macrophages that accumulate in the lamina propria of the small intestine, mesenteric lymph nodes, and other organs. These macrophages contain PAS-positive, diastase-resistant granules representing partially digested bacterial glycoprotein cell walls, confirmed by electron microscopy showing rod-shaped bacilli. The classic presentation includes arthralgias, chronic diarrhea with malabsorption, weight loss, and CNS or cardiac involvement, predominantly in older men. Treatment requires prolonged antibiotic therapy, typically ceftriaxone followed by trimethoprim-sulfamethoxazole.

• A. Mycobacterium avium-intracellulare causes a similar PAS-positive macrophage infiltrate in immunocompromised patients, but acid-fast staining would be positive and this organism lacks the characteristic trilaminar bacillus of Whipple disease.
• B. Tropical sprue shows villous blunting with a nonspecific inflammatory infiltrate, not PAS-positive foamy macrophages.
• D. Celiac disease shows villous atrophy and intraepithelial lymphocytosis, not PAS-positive macrophages.
• E. Intestinal lymphangiectasia shows dilated lymphatics without PAS-positive macrophages or bacilli.

Lactase deficiency results from reduced brush-border lactase activity, which normally hydrolyzes lactose into glucose and galactose for absorption. Unabsorbed lactose remains in the intestinal lumen, creating an osmotic gradient that draws water into the bowel, producing osmotic diarrhea with an elevated stool osmotic gap. Colonic bacteria ferment the unabsorbed lactose, generating gas (bloating) and short-chain fatty acids that lower stool pH. The best confirmatory test is the hydrogen breath test, which shows a rise in breath hydrogen after an oral lactose load because colonic bacteria metabolize the unabsorbed sugar.

• A. An invasive pathogen would cause inflammatory diarrhea with fecal leukocytes or blood, not a clean osmotic pattern tied specifically to dairy.
• B. Bacterial overgrowth with bile acid deconjugation causes fat malabsorption and steatorrhea, not the lactose-specific, pH-lowering osmotic diarrhea seen here.
• C. Autoimmune villous destruction describes celiac disease, which would show biopsy abnormalities and malabsorption of multiple nutrients, not an isolated reaction to dairy with normal histology.
• D. Secretory diarrhea from chloride channel dysfunction (e.g., cholera toxin) continues despite fasting, unlike this food-triggered pattern.

Primary ileal (midgut) carcinoid tumors drain via the portal vein, so serotonin and other vasoactive substances they secrete are metabolized by the liver before reaching systemic circulation, preventing symptoms. Once the tumor metastasizes to the liver, the metastatic deposits secrete serotonin directly into the hepatic veins, bypassing hepatic first-pass metabolism and entering the systemic circulation. This produces the classic carcinoid syndrome: flushing, secretory diarrhea, and bronchospasm. Carcinoid syndrome from a midgut primary therefore typically indicates hepatic metastatic spread.

• A. Histamine release from stellate cells is not an established mechanism of carcinoid syndrome, which is primarily serotonin-mediated.
• B. Ectopic ACTH would cause Cushing syndrome features, not flushing, diarrhea, and wheezing.
• D. Biliary obstruction is not the mechanism; serotonin is metabolized to 5-HIAA by hepatic monoamine oxidase, not cleared via bile.
• E. Tumor burden alone does not explain the symptom switch; the hepatic portal drainage before metastasis still allows complete first-pass clearance regardless of primary tumor size.

The clinical picture of flushing, diarrhea, wheezing, and a tricuspid regurgitation murmur (worsened by inspiration, from carcinoid heart disease) in a patient with a liver lesion strongly suggests carcinoid syndrome with hepatic metastasis. Serotonin is metabolized to 5-hydroxyindoleacetic acid (5-HIAA), which is excreted in urine, making a 24-hour urine 5-HIAA level the standard confirmatory test. Elevated levels support the diagnosis and can be used to monitor treatment response. Plasma chromogranin A is also useful as a tumor marker, but urine 5-HIAA is the classic diagnostic test for carcinoid syndrome specifically.

• A. Urine metanephrines screen for pheochromocytoma, which causes episodic hypertension, palpitations, and headache, not this presentation.
• B. Calcitonin is a marker for medullary thyroid carcinoma, unrelated to this presentation.
• D. Serum gastrin is elevated in Zollinger-Ellison syndrome, which causes peptic ulcers and diarrhea but not flushing or carcinoid heart disease.
• E. VIP is elevated in VIPoma (WDHA syndrome: watery diarrhea, hypokalemia, achlorhydria), which does not cause flushing or the described murmur.

Crohn disease characteristically produces skip lesions, segments of diseased bowel separated by normal mucosa, most commonly affecting the terminal ileum, and can involve any part of the GI tract from mouth to anus. Transmural inflammation (through all layers of the bowel wall) distinguishes it from ulcerative colitis, which is limited to the mucosa and submucosa. Noncaseating granulomas are a classic histologic finding in Crohn disease, along with cobblestoning from alternating ulceration and mucosal edema. Extraintestinal manifestations such as oral aphthous ulcers and perianal fistulas, from transmural fistula formation, are also typical.

• B. Ischemic colitis affects watershed areas (splenic flexure, rectosigmoid) and shows mucosal necrosis, not granulomas or chronic skip lesions.
• C. Campylobacter colitis is an acute, self-limited infection with neutrophilic crypt inflammation, not chronic transmural granulomatous disease.
• D. Intestinal tuberculosis can mimic Crohn disease but typically shows caseating granulomas and is associated with pulmonary TB or exposure history.
• E. Ulcerative colitis shows continuous mucosal inflammation starting in the rectum, without skip lesions, granulomas, or transmural involvement.

Ulcerative colitis produces continuous mucosal inflammation that always begins in the rectum and extends proximally without skip lesions, in contrast to the discontinuous skip lesions of Crohn disease. Histology shows inflammation confined to the mucosa and submucosa with crypt abscesses, collections of neutrophils within crypt lumina that damage the crypt architecture. Chronic mucosal damage and regeneration produce pseudopolyps, islands of regenerating mucosa surrounded by ulcerated areas. Bloody diarrhea with tenesmus and the rectal-predominant, continuous pattern are classic for ulcerative colitis.

• A. Pseudomembranous colitis is caused by Clostridioides difficile toxin and shows yellow adherent pseudomembranes, not crypt abscesses with chronic pseudopolyps.
• B. Crohn disease shows skip lesions and transmural granulomatous inflammation, not continuous rectal-based mucosal disease with crypt abscesses.
• C. Amebic colitis causes flask-shaped ulcers with trophozoites on biopsy, not crypt abscesses and pseudopolyps.
• E. Diverticulitis causes localized inflammation around diverticula, typically in the sigmoid colon, not continuous rectal-based disease.

Ulcerative colitis, suggested here by continuous rectal-based colonic inflammation without skip lesions, is associated with positive perinuclear ANCA (p-ANCA) in a majority of patients. Anti-Saccharomyces cerevisiae antibody (ASCA) is instead associated with Crohn disease. The combination of p-ANCA positive and ASCA negative serology supports ulcerative colitis over Crohn disease when the diagnosis is uncertain, though colonoscopic and histologic findings remain the primary basis for diagnosis. c-ANCA is instead associated with granulomatosis with polyangiitis, unrelated to inflammatory bowel disease.

• A. Both markers being positive is not the typical discriminating pattern used to distinguish these two diseases.
• B. c-ANCA is associated with granulomatosis with polyangiitis (anti-proteinase 3), not inflammatory bowel disease.
• C. Anti-CCP antibody is associated with rheumatoid arthritis and is not used in inflammatory bowel disease serologic evaluation.
• D. ASCA positivity with negative p-ANCA is the pattern associated with Crohn disease, not the continuous rectal-based colitis described here.

Toxic megacolon is a life-threatening complication of severe ulcerative colitis in which transmural inflammation extends beyond the mucosa to damage the muscularis and myenteric (Auerbach) plexus, causing colonic smooth muscle paralysis and dilation. This differs from the typical mucosa-limited inflammation of UC. Radiographic criteria include colonic diameter greater than 6 cm with systemic toxicity (fever, tachycardia, hypotension) and loss of haustration. Management includes bowel rest, IV corticosteroids, broad-spectrum antibiotics, and surgical consultation, since perforation carries high mortality.

• A. Pseudomembrane formation describes Clostridioides difficile colitis, which can complicate or mimic a UC flare but is not the mechanism of toxic megacolon itself.
• B. An obstructing adenocarcinoma produces a localized, gradually progressive obstruction rather than acute transmural paralysis with systemic toxicity.
• C. Sigmoid volvulus causes focal twisting and a characteristic "coffee bean" sign on imaging, distinct from the diffuse colonic dilation described here.
• D. Mesenteric arterial embolism causes acute ischemic colitis with patchy mucosal infarction, not the diffuse colonic dilation seen in toxic megacolon.

Infliximab is a chimeric monoclonal antibody against TNF-α. TNF-α is essential for maintaining the integrity of granulomas that wall off latent Mycobacterium tuberculosis. Blocking TNF-α disrupts granuloma architecture, allowing dormant bacilli to reactivate and cause active TB, which can present atypically or disseminate. All patients must be screened with a tuberculin skin test or interferon-gamma release assay (and chest imaging) before starting anti-TNF therapy, and those with evidence of latent TB should receive prophylactic treatment first.

• A. Infliximab's primary mechanism is TNF-α neutralization, not direct suppression of NK cell cytotoxicity.
• C. Infliximab does not cause direct CD4+ T-cell depletion; its effect is mediated through TNF-α neutralization, which secondarily destabilizes granulomas.
• D. Granuloma maintenance, not neutrophil chemotaxis, is the key TNF-α dependent process disrupted by anti-TNF therapy.
• E. Infliximab does not act by increasing IL-10 production, and this is not the established mechanism of TB reactivation.

This patient has uncomplicated acute diverticulitis, evidenced by localized CT findings (wall thickening, fat stranding) without abscess, perforation, or peritonitis. In an immunocompetent patient who can tolerate oral intake and has mild systemic symptoms, outpatient management with oral antibiotics (such as a fluoroquinolone plus metronidazole, or amoxicillin-clavulanate) and a temporary low-residue or clear liquid diet is appropriate, with close follow-up. Colonoscopy should be deferred for 6-8 weeks after resolution of the acute episode to avoid perforation risk and to exclude malignancy. Surgery and percutaneous drainage are reserved for complicated diverticulitis with abscess, perforation, or failure of medical therapy.

• B. Mesalamine is used for inflammatory bowel disease, not acute diverticulitis, which is an infectious/inflammatory process requiring antibiotics.
• C. Colonoscopy during acute diverticulitis increases perforation risk and should be delayed 6-8 weeks after the episode resolves.
• D. Emergency surgery is reserved for complicated diverticulitis with perforation, peritonitis, or failed medical management, none of which are present here.
• E. Percutaneous drainage is indicated for a diverticular abscess, which is absent on this patient's CT scan.

The splenic flexure is a classic watershed area because it lies at the junction between the territories supplied by the superior mesenteric artery (via the middle colic artery) and the inferior mesenteric artery (via the left colic artery), where collateral blood flow (marginal artery of Drummond) is often sparse or poorly developed. During systemic hypoperfusion, such as hypotension from sepsis, these watershed regions receive the least collateral compensation and are the first to become ischemic. The rectosigmoid junction (Sudeck point) is similarly vulnerable for the same reason. This contrasts with acute mesenteric ischemia from arterial occlusion, which typically affects the small bowel supplied by the SMA.

• B. Vulnerability relates to collateral circulation at arterial boundary zones, not simple distance from the aorta.
• C. The splenic flexure's vulnerability arises from being at a watershed boundary between two arterial territories with limited collaterals, not from relying on a single end-artery.
• D. The splenic flexure receives dual supply from both the SMA and IMA territories; it is the boundary between them, not exclusive IMA supply, that creates vulnerability.
• E. Watershed vulnerability is due to limited collateral perfusion, not a regional difference in muscularis propria thickness.

Angiodysplasia (vascular ectasia) is an acquired degenerative lesion, most common in the cecum and ascending colon, resulting from chronic low-grade ischemia and intermittent venous outflow obstruction as submucosal veins pass through the muscularis propria during normal bowel wall contraction. Over years, repeated partial obstruction causes submucosal veins and overlying mucosal capillaries to dilate and become tortuous, forming thin-walled, fragile ectatic vessels prone to bleeding. The association with aortic stenosis (Heyde syndrome) is thought to involve acquired von Willebrand factor deficiency from shear-induced destruction of von Willebrand multimers as blood crosses the stenotic valve, impairing hemostasis at these fragile vessels rather than causing the vascular lesion itself. This is a leading cause of lower GI bleeding and obscure GI bleeding in elderly patients.

• A. There is no immune complex deposition or vasculitic process involved in angiodysplasia; the lesion is purely degenerative.
• B. The aortic stenosis contributes to bleeding risk through acquired von Willebrand syndrome affecting hemostasis, not through a thrombotic microangiopathy causing the vascular lesion itself.
• D. Angiodysplasia is an acquired lesion of aging, not a congenital arteriovenous malformation present from birth.
• E. Angiodysplasia is a degenerative, non-neoplastic vascular ectasia, not a true vascular tumor or malformation.

Carcinoembryonic antigen (CEA) is not sensitive or specific enough for screening but is useful for postoperative surveillance in patients with a known colorectal cancer history. A rising CEA after normalization following curative resection is a sensitive indicator of tumor recurrence or metastasis and should prompt further workup with imaging (CT) and colonoscopy, even before symptoms or exam findings appear. CEA elevation can also occur in other malignancies and benign conditions (smoking, inflammatory bowel disease), limiting its specificity. Its clinical value lies in trending the marker over time in a patient with established disease, not as a diagnostic or screening test in the general population.

• A. CEA is not a validated screening tool for asymptomatic individuals, regardless of family history.
• B. A rising CEA cannot localize or confirm a new primary; it requires imaging to identify the source.
• C. CEA lacks specificity, which is exactly why it is not used for screening, but it still has value in surveillance of known disease.
• E. A sustained rise after normalization is abnormal and warrants investigation, not reassurance.

Right-sided colon cancers, most commonly in the cecum and ascending colon, tend to grow as bulky, exophytic, ulcerating masses that cause chronic occult blood loss rather than obstruction, because the right colon has a larger luminal diameter and more liquid stool. This presents with iron deficiency anemia (microcytic, low MCV) and fatigue rather than overt changes in bowel habits. Left-sided cancers (sigmoid, descending colon) tend to grow in an annular, napkin-ring pattern around the narrower lumen and more solid stool, producing obstructive symptoms, change in bowel caliber, and hematochezia. The absence of bowel habit change together with occult bleeding and iron deficiency anemia points to a right-sided lesion.

• B. Sigmoid lesions typically cause obstructive symptoms and changes in bowel habit due to the narrow lumen and solid stool.
• C. The splenic flexure is a left-sided location and tumors there behave like other left colon cancers.
• D. Descending colon tumors behave like other left-sided cancers, favoring obstruction over occult bleeding.
• E. Rectal tumors usually present with hematochezia, tenesmus, or narrowing of stool caliber.

Alcoholic hepatitis is characterized histologically by hepatocyte swelling (ballooning degeneration), Mallory-Denk bodies (eosinophilic cytoplasmic inclusions composed of aggregated intermediate filaments), and a neutrophilic infiltrate surrounding damaged hepatocytes, often with perivenular fibrosis. The AST:ALT ratio greater than 2:1 in this patient supports alcoholic liver injury, as alcohol preferentially depletes hepatic pyridoxal phosphate needed for ALT synthesis and causes mitochondrial AST release. Macrovesicular steatosis can occur in simple fatty liver but does not by itself indicate the inflammatory hepatitis seen here. The combination of ballooning, Mallory bodies, and neutrophils is the histologic hallmark that distinguishes alcoholic hepatitis from other causes of liver injury.

• A. Caseating granulomas suggest an infectious or granulomatous process such as tuberculosis, not alcoholic liver disease.
• B. Periportal lymphocytic infiltrate with interface hepatitis is characteristic of chronic viral or autoimmune hepatitis, not alcoholic hepatitis.
• D. Steatosis alone without inflammation describes simple fatty liver (steatosis), a milder and reversible stage, not alcoholic hepatitis.
• E. Ground-glass hepatocytes are characteristic of chronic hepatitis B infection due to accumulation of HBsAg, not alcohol-related injury.

Cirrhosis causes architectural distortion of the liver with fibrosis and regenerative nodules, markedly increasing resistance to portal venous blood flow. This back-pressure (portal hypertension) forces blood to find alternative routes back to the systemic circulation through portosystemic anastomoses, which become dilated: the left gastric vein anastomoses with the esophageal venous plexus (esophageal varices), the paraumbilical veins reopen and connect to superficial abdominal veins (caput medusae), and the superior rectal vein anastomoses with the middle and inferior rectal veins (hemorrhoids). This single mechanism, increased portal venous resistance and pressure, explains all three findings described, distinguishing it from systemic effects like coagulopathy, hyperestrogenism, or hypoalbuminemia, which cause other manifestations of liver disease but not these specific anastomotic dilations.

• B. Ammonia accumulation causes hepatic encephalopathy, not the vascular findings described in this patient.
• C. Reduced estrogen clearance causes spider angiomata, gynecomastia, and palmar erythema, not these specific portosystemic shunts.
• D. Decreased clotting factor synthesis contributes to bleeding risk but does not explain the formation of these dilated venous anastomoses.
• E. Hypoalbuminemia contributes to ascites and edema through reduced oncotic pressure but does not explain variceal or hemorrhoidal formation.

Lactulose is a non-absorbable disaccharide that reaches the colon undigested, where bacteria metabolize it into short-chain organic acids (such as lactic and acetic acid). This acidifies the colonic lumen, converting absorbable ammonia (NH3) into non-absorbable ammonium (NH4+), which is trapped in the gut and excreted in the stool. Lactulose also acts as an osmotic laxative, increasing colonic transit and further reducing ammonia absorption. This lowers systemic ammonia levels, which are thought to contribute to hepatic encephalopathy by causing astrocyte swelling and altered neurotransmission in the brain. Rifaximin, a nonabsorbable antibiotic, is used as an adjunct that reduces ammonia-producing gut bacteria, but this is a distinct mechanism from lactulose's acidification effect.

• A. Urease inhibition describes a potential mechanism of antibiotics like rifaximin, not lactulose, which works through acidification and trapping.
• B. Lactulose acts locally within the intestinal lumen and is not absorbed into the systemic circulation to chelate ammonia.
• C. Lactulose does not act by altering hepatic blood flow or hepatic metabolic capacity.
• D. Lactulose does not inhibit glutaminase; its effect is mediated through colonic bacterial metabolism, not enzyme inhibition.

Alpha-fetoprotein (AFP) is the serum tumor marker most associated with hepatocellular carcinoma (HCC), elevated in the majority of cases, and used alongside imaging to support the diagnosis in high-risk patients such as those with chronic HBV or HCV infection, cirrhosis, or aflatoxin exposure from Aspergillus-contaminated food. Chronic HBV infection promotes hepatocarcinogenesis through direct viral integration into host DNA and chronic inflammation-driven regeneration, even in the absence of cirrhosis, unlike HCV which usually requires cirrhosis as an intermediate step. A hepatic bruit, nodular hepatomegaly, and a liver mass in a patient with known chronic HBV strongly suggest HCC, for which AFP is the characteristic marker. AFP is not specific enough to use alone for diagnosis but is a key supportive test in the correct clinical context.

• A. CA-125 is a marker for ovarian cancer, not liver malignancy.
• B. CEA is more associated with colorectal and other gastrointestinal adenocarcinomas, not primary liver cancer.
• D. Beta-hCG is elevated in germ cell tumors and gestational trophoblastic disease, not hepatocellular carcinoma.
• E. CA 19-9 is associated with pancreatic and biliary tract cancers, not hepatocellular carcinoma.

Wilson disease is caused by autosomal recessive mutations in ATP7B, which encodes a copper-transporting ATPase in hepatocytes responsible for incorporating copper into ceruloplasmin and excreting excess copper into bile. Loss of this transporter function causes copper to accumulate in hepatocytes, leading to liver damage, and eventually spill over into the bloodstream and deposit in other tissues, including the basal ganglia (causing the movement disorder and personality changes) and the cornea (Kayser-Fleischer rings from copper deposition in Descemet membrane). Serum ceruloplasmin is typically low because ATP7B is also required for ceruloplasmin synthesis and secretion. The combination of neuropsychiatric symptoms, Kayser-Fleischer rings, and low ceruloplasmin in a young patient, especially with a similarly affected sibling, is classic for Wilson disease.

• A. Wilson disease involves a transport defect, not a primary lysosomal storage disorder.
• C. Wilson disease is a genetic transport defect, not an autoimmune process.
• D. The defect in Wilson disease is in hepatocyte copper excretion via ATP7B, not in intestinal copper absorption.
• E. This describes hereditary hemochromatosis, which involves iron overload, not copper accumulation.

Hereditary hemochromatosis is most commonly caused by mutations in the HFE gene on chromosome 6, which disrupts the normal sensing of iron stores and leads to inappropriately low production of hepcidin by the liver. Hepcidin normally inhibits ferroportin-mediated iron export from enterocytes and macrophages; low hepcidin levels therefore permit unregulated, excessive intestinal iron absorption and release of iron into the circulation. Over time this causes iron deposition in the liver, pancreas, skin, joints, and heart, producing the classic triad of micronodular cirrhosis, diabetes mellitus (bronze diabetes), and skin hyperpigmentation, as well as arthropathy. Chronic iron deposition in the liver also markedly increases the risk of hepatocellular carcinoma, which must be screened for in affected patients.

• A. Increased hepcidin would trap iron in macrophages and decrease absorption, which is the opposite of what occurs in hemochromatosis.
• B. A defective transferrin receptor would impair cellular iron uptake, not cause systemic iron overload.
• C. Increased DMT1 from chronic inflammation is not the primary mechanism in hereditary hemochromatosis, which results from decreased hepcidin and HFE mutation.
• E. Mitochondrial ferritin overexpression is not a recognized cause of hereditary hemochromatosis.

Alpha-1 antitrypsin deficiency is caused by a point mutation (commonly the Z allele) that produces a misfolded protein unable to adopt its normal conformation for secretion. The mutant protein polymerizes and accumulates in the hepatocyte endoplasmic reticulum, forming the characteristic PAS-positive, diastase-resistant globules seen on biopsy. This accumulation can cause hepatocyte injury and cirrhosis, while the resulting lack of circulating antitrypsin allows unopposed neutrophil elastase activity in the lung, destroying alveolar walls and causing panacinar emphysema (worse in lower lobes due to greater perfusion/elastase delivery). The low alpha-1 globulin band on electrophoresis reflects the deficient protein.

• B. Chronic HBV causes ground-glass hepatocytes with HBsAg accumulation, not PAS-positive globules.
• C. Describes Wilson disease, which causes Kayser-Fleischer rings and basal ganglia injury, not PAS-positive globules.
• D. Describes primary biliary cholangitis, not associated with emphysema.
• E. Describes hereditary hemochromatosis, which shows hemosiderin-laden hepatocytes on Prussian blue stain.

Primary biliary cholangitis is a chronic autoimmune disease characterized by lymphocytic destruction of small and medium intrahepatic bile ducts, producing a cholestatic pattern (markedly elevated alkaline phosphatase with mild transaminase elevation) in a middle-aged woman with pruritus, fatigue, and xanthelasmas from hyperlipidemia. The antimitochondrial antibody, directed against the E2 subunit of the pyruvate dehydrogenase complex, is highly specific and is the serologic hallmark of the disease. It is strongly associated with other autoimmune conditions such as Sjögren syndrome.

• A. Primary sclerosing cholangitis is associated with p-ANCA and ulcerative colitis, with a beaded appearance of bile ducts on cholangiography, not antimitochondrial antibody.
• C. Hepatitis C causes a hepatocellular injury pattern and is diagnosed by HCV antibody and RNA testing, not antimitochondrial antibody.
• D. Alcoholic hepatitis causes an AST:ALT ratio greater than 2 and is unlikely given no history of alcohol use.
• E. Autoimmune hepatitis causes a hepatocellular pattern with markedly elevated transaminases and is associated with anti-smooth muscle and ANA antibodies, not antimitochondrial antibody.

This presentation is classic for Gilbert syndrome, a benign, common condition caused by a mildly reduced (not absent) activity of UDP-glucuronosyltransferase (UGT1A1) due to a promoter polymorphism, leading to impaired conjugation of bilirubin. Unconjugated hyperbilirubinemia becomes apparent during physiologic stress such as fasting, illness, or exertion, with normal liver enzymes and no hemolysis. In contrast, Crigler-Najjar syndrome type 1 results from complete absence of UGT1A1 activity, causing severe unconjugated hyperbilirubinemia and kernicterus in neonates. Dubin-Johnson syndrome involves a defect in canalicular multidrug resistance protein 2, causing conjugated hyperbilirubinemia with black liver pigmentation, not relevant to this patient's indirect hyperbilirubinemia.

• A. Defective canalicular transport describes Dubin-Johnson syndrome, which causes conjugated, not unconjugated, hyperbilirubinemia.
• B. Normal reticulocyte count and hemoglobin rule out hemolysis as the cause.
• D. Biliary obstruction would cause conjugated hyperbilirubinemia with elevated alkaline phosphatase, not isolated indirect hyperbilirubinemia with normal liver enzymes.
• E. Complete absence of UGT1A1 activity describes Crigler-Najjar syndrome type 1, which presents in infancy with severe hyperbilirubinemia and kernicterus, not mild adult jaundice.

This patient's risk factors (female sex, multiparity, obesity, middle age) are classic for cholesterol gallstones, the most common type in the United States. Cholesterol gallstones form when bile becomes supersaturated with cholesterol relative to the solubilizing agents bile salts and lecithin (phosphatidylcholine), promoting cholesterol crystal nucleation and precipitation. Estrogen increases cholesterol secretion into bile (explaining the female and multiparity risk), while obesity increases cholesterol synthesis and secretion. This contrasts with pigment stones, which form from calcium bilirubinate precipitation and are associated with chronic hemolysis or biliary infection.

• A. Bacterial deconjugation of bilirubin promotes brown pigment stone formation in the setting of biliary infection or infestation, not this patient's presentation.
• C. Chronic hemolysis causing increased bilirubin excretion leads to black pigment stones, not cholesterol stones.
• D. Calcium bilirubinate precipitation describes black pigment stone formation, typically associated with chronic hemolysis, not this patient's risk profile.
• E. Decreased bile acid synthesis would reduce cholesterol solubilization and could contribute to stones, but it is not the primary mechanism driven by this patient's risk factors, which act mainly by increasing cholesterol secretion.

This patient has acute cholecystitis, demonstrated by a positive Murphy sign (inspiratory arrest on right upper quadrant palpation), fever, leukocytosis, and ultrasound findings of gallbladder wall thickening and pericholecystic fluid with an obstructing stone at the cystic duct/neck. Obstruction of the cystic duct, most commonly by a gallstone, prevents gallbladder emptying, leading to increased intraluminal pressure, distension, mucosal ischemia, and secondary bacterial inflammation of the gallbladder wall. Normal bilirubin in this case reflects an unobstructed common bile duct, distinguishing cholecystitis from choledocholithiasis or cholangitis.

• A. Vasculitis is not the mechanism of calculous cholecystitis; the pathology is obstructive and secondarily inflammatory/ischemic, not primarily vasculitic.
• B. Common bile duct obstruction with bacterial ascent describes ascending cholangitis, which would typically cause elevated bilirubin and jaundice, not seen here.
• C. Reflux of bile into the pancreatic duct is a proposed mechanism of gallstone pancreatitis, not cholecystitis.
• D. Pancreatic duct obstruction describes the mechanism of gallstone pancreatitis, not cholecystitis, and would present with epigastric pain and elevated lipase.

This patient has Reynolds pentad (fever, jaundice, right upper quadrant pain, hypotension, and altered mental status), an extension of Charcot triad indicating severe, life-threatening ascending cholangitis. The underlying cause is biliary obstruction, most commonly from a common bile duct stone (choledocholithiasis), which causes bile stasis and allows ascending bacterial infection of the biliary tree, typically by enteric gram-negative organisms such as Escherichia coli, Klebsiella, and Enterococcus. This is a surgical and infectious emergency requiring urgent biliary decompression (ERCP) and antibiotics.

• A. Autoimmune bile duct destruction (as in PBC or PSC) is a chronic process and would not explain acute bacteremia and septic shock.
• B. Acute pancreatitis typically causes epigastric pain with elevated lipase, not the obstructive jaundice and bacteremia characteristic of cholangitis.
• C. Viral hepatitis causes a hepatocellular pattern with markedly elevated transaminases, not the obstructive pattern with bacteremia seen here.
• D. Cirrhosis with portal hypertension does not directly cause fever, bacteremia, and an obstructive biliary picture with E. coli growth.

This patient's presentation of acute pancreatitis (epigastric pain radiating to the back, markedly elevated lipase greater than 3 times the upper limit of normal) combined with gallstones on ultrasound and elevated liver enzymes with a dilated common bile duct strongly suggests gallstone pancreatitis. A gallstone impacted at the ampulla of Vater obstructs both the pancreatic duct and common bile duct, causing pancreatic enzyme activation within the gland and resultant autodigestion, along with the cholestatic liver enzyme pattern seen here. Gallstones and alcohol use together account for the large majority of acute pancreatitis cases, and in a patient without a significant alcohol history, biliary obstruction is the most likely etiology.

• A. This patient lacks a history of alcohol abuse, and chronic ethanol-induced disease would more typically show a history of recurrent pancreatitis and ductal calcifications.
• C. Autoimmune pancreatitis is a rare, chronic condition typically presenting with obstructive jaundice and a diffusely enlarged "sausage-shaped" pancreas, not this acute presentation with gallstones.
• D. Hypertriglyceridemia-induced pancreatitis typically occurs with triglyceride levels above 1000 mg/dL, which was not measured or suggested here, and would not explain the biliary duct dilation and gallstones.
• E. Scorpion venom is a rare cause of acute pancreatitis reported in specific geographic regions and is not suggested by this patient's history.

A pancreatic pseudocyst is a localized collection of pancreatic fluid rich in amylase and lipase that develops as a complication of acute or chronic pancreatitis, typically presenting weeks after the initial episode as a palpable abdominal mass with persistent pain and mildly elevated pancreatic enzymes. Unlike true cysts or neoplastic cystic lesions, a pseudocyst lacks an epithelial lining; instead, it is walled off by fibrous and granulation tissue, which is the defining histologic feature distinguishing it from true cystic neoplasms. Management depends on size and symptoms, with many resolving spontaneously, while large or symptomatic pseudocysts may require drainage.

• A. Pancreatic ductal adenocarcinoma presents as a solid infiltrative mass, often with obstructive jaundice and weight loss, not a fluid-filled collection following pancreatitis.
• B. Mucinous cystic neoplasm is lined by mucin-producing columnar epithelium with a premalignant potential, not a fibrous wall without epithelium, and is not a direct consequence of acute pancreatitis.
• C. Serous cystadenoma is a benign neoplasm lined by glycogen-rich cuboidal epithelium, typically found incidentally and unrelated to a recent pancreatitis episode.
• D. A pancreatic abscess presents with signs of infection such as high fever and marked leukocytosis, and contains purulent material rather than a fibrous-walled fluid collection.

Achalasia results from degeneration of inhibitory neurons (producing nitric oxide and VIP) in the myenteric (Auerbach) plexus of the lower esophageal sphincter, causing failure of LES relaxation and loss of coordinated peristalsis. This produces functional obstruction with proximal dilation, giving the classic 'bird-beak' tapering on barium swallow. Idiopathic achalasia is thought to have an autoimmune component targeting these neurons. Treatment options include pneumatic dilation, myotomy, or botulinum toxin injection to the LES.

• A. The myenteric, not submucosal, plexus is primarily affected, and the process is not isolated to Meissner plexus.
• B. Vascular compression (dysphagia lusoria) causes mechanical, not motor, dysphagia with a different imaging pattern.
• C. Muscle hypertrophy is a secondary consequence, not the primary defect driving the disease.
• D. GERD causes strictures from fibrosis, but the esophagram findings and lack of reflux history point away from this.

Esophageal manometry is the gold-standard test to distinguish motility disorders: achalasia shows elevated LES resting pressure with incomplete/absent relaxation on swallowing and absent peristalsis, whereas diffuse esophageal spasm shows repetitive, high-amplitude, simultaneous (non-peristaltic) contractions with normal LES relaxation. Barium studies can suggest the diagnosis (bird-beak in achalasia, corkscrew in spasm) but are not definitive. Endoscopy is used mainly to exclude pseudoachalasia from malignancy. Manometry directly measures the pressure and coordination abnormalities that define each disorder.

• A. pH monitoring assesses acid reflux burden, not motility patterns.
• B. Impedance testing assesses bolus transit and reflux but is not the standard for differentiating these motility disorders.
• D. CT chest can show esophageal dilation but does not assess contraction dynamics.
• E. Endoscopy evaluates the mucosa and excludes a mass lesion but cannot characterize motor function.

Chagas disease, caused by Trypanosoma cruzi (transmitted by the reduviid/triatomine bug), leads to chronic destruction of autonomic ganglion cells, including the myenteric plexus of the esophagus and colon, producing megaesophagus and megacolon that mimic idiopathic achalasia. The parasite also causes dilated cardiomyopathy with apical aneurysm formation and arrhythmias, as seen in this patient. The epidemiologic clue (rural South America) combined with cardiac and GI involvement points to Chagas disease. This is a classic cause of secondary achalasia.

• A. Strongyloides causes GI symptoms and hyperinfection in immunosuppressed patients but does not cause megaesophagus or cardiomyopathy.
• B. Leishmania causes visceral disease with hepatosplenomegaly and pancytopenia, not cardiomyopathy or megaesophagus.
• C. Toxoplasma causes CNS and ocular disease, not myenteric plexus destruction.
• D. Entamoeba causes dysentery and liver abscess, not esophageal dysmotility.

Boerhaave syndrome is a transmural (full-thickness) rupture of the esophagus, classically occurring at the left posterolateral wall of the distal esophagus, caused by a sudden increase in intraesophageal pressure during forceful vomiting against a closed glottis. It presents with severe chest pain, fever, tachycardia, hypotension, and subcutaneous emphysema (crepitus) from air tracking into the mediastinum and soft tissue (Mackler triad: vomiting, chest pain, subcutaneous emphysema). It is a surgical emergency requiring prompt diagnosis and repair, as mediastinitis carries high mortality if untreated. This differs from Mallory-Weiss tear, which involves only mucosal/submucosal laceration without perforation.

• B. Pneumothorax would show absent breath sounds and hyperresonance, not a history of forceful vomiting with chest wall crepitus specifically from esophageal rupture.
• C. A perforated ulcer typically causes epigastric pain with peritoneal signs, not crepitus from air tracking into the chest wall.
• D. A mucosal laceration (Mallory-Weiss tear) causes hematemesis, not subcutaneous emphysema or mediastinitis.
• E. Pancreatitis causes epigastric pain radiating to the back, not subcutaneous emphysema.

A Mallory-Weiss tear is a longitudinal mucosal and submucosal laceration at the gastroesophageal junction caused by a sudden rise in intra-abdominal pressure during forceful retching or vomiting, classically seen in bulimia or alcohol use. It presents with hematemesis following vomiting and is usually self-limited since the defect does not extend through the muscular wall, unlike Boerhaave syndrome. Endoscopy confirms the diagnosis and most tears heal without intervention. Risk factors include alcoholism, bulimia, and hyperemesis gravidarum.

• A. Erosive esophagitis presents with diffuse mucosal inflammation, not a focal linear laceration from retching.
• C. Boerhaave syndrome involves full-thickness rupture with mediastinitis, not an isolated mucosal tear.
• D. Variceal rupture occurs in patients with portal hypertension and presents with massive hematemesis from dilated submucosal veins, not a linear tear from retching.
• E. A Dieulafoy lesion is a dilated aberrant submucosal artery causing bleeding without a preceding ulcer or tear, unrelated to vomiting.

Barrett esophagus is defined by metaplasia, a reversible adaptive change in which the normal stratified squamous epithelium of the distal esophagus is replaced by intestinal-type columnar epithelium containing goblet cells, in response to chronic acid and bile reflux from GERD. This intestinal metaplasia is identified histologically by the presence of goblet cells, which distinguishes it from simple gastric-type columnar metaplasia (which lacks goblet cells and does not meet criteria for Barrett esophagus). Metaplasia is distinct from dysplasia, which refers to cytologic/architectural atypia and is a separate step toward malignancy. Barrett esophagus is clinically significant because it is a precursor lesion for esophageal adenocarcinoma.

• A. Gastric-type columnar metaplasia lacking goblet cells does not meet histologic criteria for Barrett esophagus, which requires intestinal metaplasia.
• B. Esophageal submucosal gland hyperplasia does not produce the goblet cell-containing columnar surface epithelium seen in Barrett esophagus.
• C. Squamous hyperplasia would show thickening of the squamous epithelium, not conversion to columnar epithelium with goblet cells.
• D. Dysplasia refers to atypical cellular changes within existing epithelium, not a change in cell type; it is a later step that can occur within Barrett mucosa.

Barrett esophagus follows a well-described progression: chronic GERD causes squamous-to-columnar intestinal metaplasia, which over time can accumulate genetic alterations leading to low-grade and then high-grade dysplasia, and ultimately invasive esophageal adenocarcinoma. The biopsy findings described (nuclear atypia and architectural disorganization without invasion) represent dysplasia, an intermediate step that carries an increased risk of progression to carcinoma, warranting closer surveillance or endoscopic therapy. This metaplasia-dysplasia-carcinoma sequence underlies the rationale for periodic endoscopic surveillance in patients with Barrett esophagus.

• A. Barrett esophagus arises from columnar metaplasia, not squamous hyperplasia.
• B. Dysplasia is a precancerous change that does not spontaneously regress to normal squamous epithelium.
• C. Barrett-associated cancer is adenocarcinoma, not squamous cell carcinoma, and chronic inflammation alone does not directly cause carcinoma without the metaplasia-dysplasia sequence.
• E. An intermediate dysplastic step precedes invasive carcinoma; it does not occur directly from metaplasia.

This patient's upper-third esophageal mass with a history of chronic alcohol and tobacco use, but no reflux history, is most consistent with squamous cell carcinoma, which typically arises in the proximal to mid-esophagus. Alcohol and tobacco act synergistically as major risk factors for esophageal SCC through direct mucosal irritation and carcinogen exposure. In contrast, esophageal adenocarcinoma typically arises in the distal esophagus from Barrett esophagus and is linked to GERD and obesity. Other SCC risk factors include achalasia, caustic strictures, and consumption of very hot liquids.

• A. Bisphosphonates can cause pill-induced esophagitis but are not a major risk factor for either cancer type.
• C. GERD is a risk factor for adenocarcinoma, which arises in the distal esophagus, not the squamous cell carcinoma described here.
• D. Intestinal metaplasia (Barrett esophagus) is a precursor to adenocarcinoma, not SCC.
• E. Obesity increases adenocarcinoma risk via reflux-driven mechanisms, not squamous cell carcinoma.